We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current GNMLF market cap is 1.27B. The company's latest EPS is MXN 1.0812 and P/E is 1.17.
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
MXN ($) | MXN ($) | MXN ($) | MXN ($) | MXN ($) | |
Total Revenue | 12.77B | 13.91B | 15.55B | 16.9B | 16.48B |
Operating Income | 2.41B | 2.83B | 2.96B | 3.29B | 3.2B |
Net Income | 764.46M | 1.47B | 1.31B | 1.39B | 1.08B |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
MXN ($) | MXN ($) | MXN ($) | MXN ($) | MXN ($) | |
Total Assets | 19.25B | 22.13B | 21.54B | 21.61B | 20.74B |
Total Liabilities | 11.28B | 12.5B | 11.47B | 11.45B | 11.3B |
Total Equity | 7.97B | 9.63B | 10.07B | 10.15B | 9.44B |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
MXN ($) | MXN ($) | MXN ($) | MXN ($) | MXN ($) | |
Operating | 1.01B | 1.71B | 1.47B | 2.05B | 2.25B |
Investing | -844.64M | -663.65M | -765.62M | -282.3M | -302.21M |
Financing | -621.94M | 189.85M | -1.47B | -1.36B | -1.68B |
Market Cap | 1.27B |
Price to Earnings Ratio | 1.17 |
Price to Sales Ratio | 0.08 |
Price to Cash Ratio | 0.86 |
Price to Book Ratio | 0.13 |
Dividend Yield | - |
Shares Outstanding | 1B |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 5.97k |
52 Week Change | 59.55% |
52 Week High | 1.275 |
52 Week Low | 0.79 |
Spread (Intraday) | 0.25 (17.24%) |
Company Name | Genoma Lab International SAB DE CV (PK) |
Address |
avenida antonio dovali jaime no. 70, torre a,piso 2 mexico city, distrito federal 01210 |
Website | https://www.genommalab.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions